Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2025-04-25

FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Eugia US LLC)

View source ↗

Summary

FDA approved a supplemental application for pantoprazole sodium by Eugia US LLC, resulting in a labeling update for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pantoprazole sodium (pantoprazole sodium)

Snippet

SUPPL AP for PANTOPRAZOLE SODIUM (PANTOPRAZOLE SODIUM)